PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcomaEGA study EGAS00001001281
创建时间：
2017-07-26
